Sodium Glucose Cotransporter 2 Inhibition and the Visualization of Kidney Hemodynamics

被引：10
作者：
Wanner, Christoph [1 ]
机构：
[1] Univ Hosp Wurzburg, Dept Med, Div Nephrol, Oberdurrbacherstr 6, D-97080 Wurzburg, Germany
来源：
CIRCULATION | 2019年 / 140卷 / 04期
关键词：
Editorials; diabetes mellitus; type; 2; glomerular filtration rate; hemodynamics; microscopy; fluorescence; multiphoton; sodium glucose transporter 2 inhibitors; EMPAGLIFLOZIN; OUTCOMES; DISEASE;
D O I：
10.1161/CIRCULATIONAHA.119.040326
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：316 / 318
页数：3
相关论文
共 50 条
  • [31] Energy Balance After Sodium-Glucose Cotransporter 2 Inhibition
    Ferrannini, Giulia
    Hach, Thomas
    Crowe, Susanne
    Sanghvi, Arjun
    Hall, Kevin D.
    Ferrannini, Ele
    DIABETES CARE, 2015, 38 (09) : 1730 - 1735
  • [32] Sodium-Glucose Cotransporter 2 Inhibitors and Kidney Outcomes across the Spectrum of Kidney Disease A Systematic Review and Meta-Analysis
    Spiazzi, Bernardo F.
    Piccoli, Giovana F.
    Wayerbacher, Laura F.
    Lubianca, Joao Pedro N.
    Scalco, Bruno G.
    Scheffler, Mariana H.
    Fraga, Bruna L.
    Colpani, Veronica
    Gerchman, Fernando
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2025, 20 (01): : 39 - 49
  • [33] Glucose Lowering Efficacy and Pleiotropic Effects of Sodium-Glucose Cotransporter 2 Inhibitors
    Kuchay, Mohammad Shafi
    Farooqui, Khalid Jamal
    Mishra, Sunil Kumar
    Mithal, Ambrish
    DIABETES: FROM RESEARCH TO CLINICAL PRACTICE, VOL 4, 2021, 1307 : 213 - 230
  • [34] Sodium glucose co-transporter 2 inhibition: a new avenue to protect the kidney
    Heerspink, Hiddo J. L.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (12) : 2015 - 2017
  • [35] Sodium-glucose cotransporter-2 inhibitors (SGLT2i) in kidney transplant recipients: what is the evidence?
    Ujjawal, Aditi
    Schreiber, Brittany
    Verma, Ashish
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2022, 13
  • [36] Effects of Sodium-Glucose Cotransporter 2 Inhibition on Glucose Metabolism, Liver Function, Ascites, and Hemodynamics in a Mouse Model of Nonalcoholic Steatohepatitis and Type 2 Diabetes
    Yabiku, Koichi
    Nakamoto, Keiko
    Tsubakimoto, Maho
    JOURNAL OF DIABETES RESEARCH, 2020, 2020
  • [37] Sodium-glucose cotransporter 2 inhibitor effects on cardiovascular outcomes in chronic kidney disease
    Shivakumar, Oshini
    Sattar, Naveed
    Wheeler, David C.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 43 - 47
  • [38] The effect of sodium glucose cotransporter 2 inhibition with empagliflozin on microalbuminuria and macroalbuminuria in patients with type 2 diabetes
    Cherney, David
    Lund, Soren S.
    Perkins, Bruce A.
    Groop, Per-Henrik
    Cooper, Mark E.
    Kaspers, Stefan
    Pfarr, Egon
    Woerle, Hans J.
    von Eynatten, Maximilian
    DIABETOLOGIA, 2016, 59 (09) : 1860 - 1870
  • [39] Sodium-glucose cotransporter 2 inhibitors as the first universal treatment of chronic kidney disease
    El Din, Usama Abdel Azim Sharaf
    Salem, Mona Mansour
    Abdulazim, Dina Ossama
    NEFROLOGIA, 2022, 42 (04): : 390 - 403
  • [40] Sodium-glucose cotransporter 2 inhibitors for treatment of diabetes mellitus after kidney transplantation
    Lemke, Adley
    Brokmeier, Hannah M.
    Leung, Sarah B.
    Mara, Kristin C.
    Mour, Girish K.
    Wadei, Hani M.
    Hill, Jennifer M.
    Stegall, Mark
    Kudva, Yogish C.
    Shah, Pankaj
    Kukla, Aleksandra
    CLINICAL TRANSPLANTATION, 2022, 36 (08)
12345